BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4135558)

  • 1. Editorial: Dimethyltryptamine and psychosis.
    Lancet; 1974 Jul; 2(7873):140-1. PubMed ID: 4135558
    [No Abstract]   [Full Text] [Related]  

  • 2. The multiple monoamine oxidases.
    Wyatt RJ
    Adv Biochem Psychopharmacol; 1974; 12(0):1-2. PubMed ID: 4529309
    [No Abstract]   [Full Text] [Related]  

  • 3. A review of recent studies of the biosynthesis and excretion of hallucinogens formed by methylation of neurotransmitters or related substances.
    Rosengarten H; Friedhoff AJ
    Schizophr Bull; 1976; 2(1):90-105. PubMed ID: 779022
    [No Abstract]   [Full Text] [Related]  

  • 4. N,N-dimethyltryptamine--a possible relationship to schizophrenia?
    Wyatt RJ; Gillin JC; Kaplan J; Stillman R; Mandel L; Ahn HS; VandenHeuvel WJ; Walker RW
    Adv Biochem Psychopharmacol; 1974; 11(0):299-313. PubMed ID: 4602668
    [No Abstract]   [Full Text] [Related]  

  • 5. The dimethyltryptamine-forming enzyme in blood platelets: a study in monozygotic twins discordant for schizophrenia.
    Wyatt RJ; Saavedra JM; Belmaker R; Cohen S; Pollin W
    Am J Psychiatry; 1973 Dec; 130(12):1359-61. PubMed ID: 4518712
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia.
    Wyatt RJ; Murphy DL; Belmaker R; Cohen S; Donnelly CH; Pollin W
    Science; 1973 Mar; 179(4076):916-8. PubMed ID: 4687789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dimethyltryptamine-forming enzyme in human blood.
    Wyatt RJ; Saavedra JM; Axelrod J
    Am J Psychiatry; 1973 Jul; 130(7):754-60. PubMed ID: 4514540
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of monoamine oxidase substrate activities in twins, schizophrenics, depressives, and controls.
    Nies A; Robinson DS; Harris LS; Lamborn KR
    Adv Biochem Psychopharmacol; 1974; 12(0):59-70. PubMed ID: 4607593
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for and against the involvement of N,N-dimethyl-tryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in schizophrenia.
    Gillin JC; Wyatt RJ
    Psychopharmacol Bull; 1976 Oct; 12(4):12-3. PubMed ID: 1067623
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet monoamine oxidase in chronic schizophrenia.
    Berrettini WH; Vogel WH; Clouse R
    Am J Psychiatry; 1977 Jul; 134(7):805-7. PubMed ID: 869060
    [No Abstract]   [Full Text] [Related]  

  • 11. The significance of some biochemical abnormalities in schizophrenia.
    Rodnight R
    Acta Neurol (Napoli); 1975; 30(1):85-101. PubMed ID: 1063539
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: Comparison of MAO substrate activities in twins, schizophrenics, depressives, and controls.
    Nies A; Robinson DS; Harris LS; Lamborn KR
    Psychopharmacol Bull; 1974 Jul; 10(3):10. PubMed ID: 4472719
    [No Abstract]   [Full Text] [Related]  

  • 13. 5-methoxy-N, N-dimethyltryptamine, a possible endogenous psychotoxin.
    Benington F; Morin RD; Clark LC
    Ala J Med Sci; 1965 Oct; 2(4):397-403. PubMed ID: 5892656
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence for the absence of amine-N-methylation and O-methylation in indolethylamines with methyltetrahydrofolic acid-dependent N-methyltransferase.
    Lin RL; Narasimhachari N
    Res Commun Chem Pathol Pharmacol; 1974 Jul; 8(3):535-42. PubMed ID: 4527795
    [No Abstract]   [Full Text] [Related]  

  • 15. On the relation between platelet monoamine oxidase activity and the growth hormone response in psychosis.
    Hitzemann R; Hirschowitz J; Zemlan F; Hitzemann B; Garver D
    Biol Psychiatry; 1983 Dec; 18(12):1503-7. PubMed ID: 6661478
    [No Abstract]   [Full Text] [Related]  

  • 16. Raised monoamine oxidase in acute psychosis?
    Brockington IF; Owen F
    Br J Psychiatry; 1980 Mar; 136():312-3. PubMed ID: 7388235
    [No Abstract]   [Full Text] [Related]  

  • 17. N, N-dimethyltryptamine: an endogenous hallucinogen.
    Barker SA; Monti JA; Christian ST
    Int Rev Neurobiol; 1981; 22():83-110. PubMed ID: 6792104
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet monoamine oxidase activity in anergic schizophrenics.
    Shaskan EG; Becker RE
    Psychopharmacol Bull; 1975 Jul; 11(3):39-40. PubMed ID: 1153659
    [No Abstract]   [Full Text] [Related]  

  • 19. Decreased platelet monoamine oxidase activity in chronic schizophrenia, shown with novel substrates.
    Berrettini WH; Prozialeck W; Vogel WH
    Arch Gen Psychiatry; 1978 May; 35(5):600-5. PubMed ID: 281895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of N,N-dimethyltryptamine to evoke tolerance in cats.
    Gillin JC; Cannon E; Magyar R; Schwartz M; Wyatt RJ
    Biol Psychiatry; 1973 Dec; 7(3):213-20. PubMed ID: 4519415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.